Evolus to Bring Profhilo to the United States Through New Partnership
The licensing and distribution agreement expands the company's injectable portfolio into the skin quality category.
The licensing and distribution agreement expands the company's injectable portfolio into the skin quality category.
Enrollment is complete in a phase 2 trial investigating the use of pure PDGF as an adjunctive therapy for complex surgical wounds following skin cancer excision.